Company Analysis

Onconetix, Inc. (ONCO)

Nasdaq: ONCO · Pharmaceutical Preparations · Cincinnati, OH · filing with the SEC since 2019
Grade3.3
◀ Past 2.8● Present 2.4▶ Future 4.5
2 est.

Filings

331 filings since 2017 beside 69 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 7, 2026.

Filings a yearinsider forms included
1158275986465
2019202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 17 times in the last 36 months, the newest Apr 24, 2026.Listing warning from its exchange (8-K item 3.01): 8 times in the last 36 months, the newest May 22, 2025.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Feb 18, 2025.SEC letters: 22 in the last 36 months, the newest Jun 15, 2026.A late-filing notice, Form NT 10-K, filed Apr 1, 2025.A late-filing notice, Form NT 10-Q, filed Nov 15, 2024.A late-filing notice, Form NT 10-Q, filed Aug 14, 2024.A late-filing notice, Form NT 10-Q, filed May 15, 2024.A late-filing notice, Form NT 10-K, filed Apr 1, 2024.A late-filing notice, Form NT 10-Q, filed Nov 15, 2023.
Insider forms 69

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Nov 10, 2026
Nov 9, 2026 8-K items 5.03, 9.01 Charter, bylaw or fiscal-year change · Current report Nov 4, 2026
Nov 6, 2026 425 Merger communication
Nov 6, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Nov 4, 2026
Nov 5, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 27, 2026 425 Merger communication
Oct 26, 2026 8-K items 8.01, 9.01 Other event · Current report Oct 22, 2026
Oct 23, 2026 DEFA14A Extra proxy material
Oct 23, 2026 8-K items 8.01, 9.01 Other event · Current report Oct 22, 2026
Oct 23, 2026 425 Merger communication
Oct 16, 2026 ARS Annual report to shareholders Dec 31, 2025
Oct 7, 2026 DEF 14A Proxy statement Nov 10, 2026
Sep 17, 2026 PRE 14A Preliminary proxy statement
Sep 14, 2026 DEFA14A Extra proxy material
Sep 14, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Sep 11, 2026
Sep 14, 2026 425 Merger communication
Sep 8, 2026 424B3 Shelf offering
Sep 3, 2026 EFFECT Registration effective
Sep 3, 2026 425 Merger communication
Aug 31, 2026 S-1/A Listing registration, amended
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 12, 2026 S-1 Listing registration
Aug 6, 2026 425 Merger communication
Jul 29, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report Jul 28, 2026
Jul 27, 2026 SCHEDULE 13G Large holder notice
Jul 7, 2026 425 Merger communication
Jun 24, 2026 425 Merger communication
Jun 17, 2026 424B3 Shelf offering
Jun 16, 2026 EFFECT Registration effective
Jun 15, 2026 CORRESP Reply to the SEC
Jun 12, 2026 UPLOAD SEC comment letter
Jun 9, 2026 S-1 Listing registration
May 19, 2026 8-K items 5.03, 8.01, 9.01 Charter, bylaw or fiscal-year change; Other event · Current report
May 14, 2026 8-K items 8.01, 9.01 Other event · Current report May 13, 2026
May 13, 2026 10-Q Quarterly report Mar 31, 2026
May 12, 2026 424B3 Shelf offering
May 11, 2026 EFFECT Registration effective
May 7, 2026 EFFECT Registration effective
May 7, 2026 S-1/A Listing registration, amended
May 7, 2026 CORRESP Reply to the SEC
40 of 331 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ONCO · research, not advice